NYSE American · AMSHealthcareMedical Labs

American Shared Hospital Services (AMS)

$1.24+0.81%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$1.23▼ 41.43% in range
Nov 3, 2025Low $1.23 · High $2.29Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

American Shared Hospital Services closed at $1.24 on Nov 4, up 0.81%, within 0.8% of its 52-week closing low. Volume of 2.0K shares was 0.20× its 20-day average (below normal).

Split-adjusted performance: -10.1% over one month, -31.5% over six months, -41.0% over one year.

In the quarter ended Jun 30, 2026, revenue was $8.43M, up 19.2% from a year earlier, with a net margin of -6.1%.

Short interest was 6.1K shares at the Oct 15 settlement, down 26.4% from the prior report (0.1% of float, 1.0 days to cover).

Market cap$8.2M6.7M shares
Revenue · quarter$8.4M+19.2% YoY
Diluted EPS$-0.07—
P/E · TTM—P/S 0.3×
Net margin-6.1%Gross 44.4%
Dividend yieldNone$0.0475 last paid
52-week range1.23 – 2.29−45.9% from high
Volume2.0K0.20× 20-day avg
Volatility · 60d36.6%Annualised
Short % of float0.1%1.0 days to cover
Net cash-$9.7MCash $6.5M
Next earnings—Not scheduled
Split-adjusted performance
1W −6.8%1M −10.1%3M −15.1%6M −31.5%YTD −41.2%1Y −41.0%3Y −45.9%5Y −56.3%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Medical Labs

Percentile among 24 companies (100 = best)

6-month momentum18
Revenue growth39
Net margin48
Value (low P/E)—
Size13

Industry medians: 6-month return +36.5%, revenue growth +25.0%, net margin −4.0%, P/E 32.5×.

Short interest

Details →
Shares short6.1K−26.4% vs prior
Days to cover1.0Settled Oct 15
% of float0.1%
Short vol. 10d28.9%of daily volume

Closest peers by size in Medical Labs

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
AMSAmerican Shared Hospital Services$1.24+0.81%−31.5%+19.2%−6.1%—$8.2M
ACONAclarion$1.77+0.68%−46.0%+30.5%−10899.5%—$5.1MCompare
ADVBAdvanced Biomed$2.24+1.82%−67.0%—544.5%0.6$3.7MCompare
BGLCBioNexus Gene Lab$0.9400−1.05%−53.0%−96.6%−376.1%—$2.8MCompare
SERASera Prognostics$2.06+6.61%+13.7%+76.5%−30463.3%—$81.2MCompare
XGNExagen$8.53+2.30%+176.1%+15.9%−16.0%—$206.7MCompare
BDSXBiodesix$21.44+1.85%+42.9%+34.2%−27.1%—$226.2MCompare
FLGTFulgent Genetics$19.86+2.50%+33.1%+4.4%−34.6%—$546.3MCompare
CSTLCastle Biosciences$35.94+2.28%+45.2%+20.1%−2.0%—$1.10BCompare

News about American Shared Hospital Services

All news →

No recent articles focused on American Shared Hospital Services.

Quick answers

What does American Shared Hospital Services do?
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities.
What is AMS's market cap?
$8.25M, based on the Nov 4 close of $1.24.
Does American Shared Hospital Services pay a dividend?
No regular cash dividend has been paid in the last year.
How much of AMS is sold short?
6.1K shares, 0.1% of float, as of Oct 15, 2026.
What sector is AMS in?
Healthcare, in the Medical Labs industry.

About American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. Company operates in two segments, the medical equipment leasing segment where a contract exists between the hospital and the Company and the direct patient services segment, where a contract exists between the Company facilities and the individual treated at the facility. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates it's key revenue from the domestic market.

HQ: San Francisco, CA84 employeesListed Sep 7, 1984ashs.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology